Has Padmaja Chilakapati received payments from drug or device companies?

Yes. Drug and device makers reported $381 in general payments to Padmaja Chilakapati across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Padmaja Chilakapati did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Padmaja Chilakapati come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Padmaja Chilakapati

Child & Adolescent Psychiatry · Uniontown, PANPI 1396990347

Payments from drug & device makers

$381in general payments, 2019–2025

Across 21 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$84
Takeda Pharmaceuticals U.S.A., Inc.$55
Otsuka America Pharmaceutical, Inc.$49
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
Vertical Pharmaceuticals, LLC$41
Bayer$34
plus $71 from 4 others

What the payments were for

Food & beverage$33488%
Education$4712%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	4	$84
Takeda Pharmaceuticals U.S.A., Inc.	3	$55
Otsuka America Pharmaceutical, Inc.	3	$49
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$47
Vertical Pharmaceuticals, LLC	3	$41
Bayer	2	$34
Johnson & Johnson	2	$22
Organogenesis Inc.	1	$19
Tandem Diabetes Care, Inc.	1	$18
Sunovion Pharmaceuticals Inc.	1	$13

How this compares

$381 in reported general payments places this provider in the 60th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.

See all child & adolescent psychiatry providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$20,823

Medicare patients

Services billed

213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sertraline Hcl	25	$356
Aripiprazole	11	$199
Trazodone Hcl	19	$137
Quetiapine Fumarate	13	$132
Fluoxetine Hcl	13	$84
Clonazepam	11	$69
Alprazolam	12	$13

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Uniontown

Dennis BorczonErie$120K
Robert BerkowitzPhiladelphia$105K
Suzanne LucotCranberry Township$72K
Dan UdreaWexford$51K
Raman BawejaHershey$44K
Robert WilsonErie$34K
Craig FeasterState College$18K
Thomas WindPhiladelphia$17K
Laura AdangPhiladelphia$15K
Christoph LamPhiladelphia$13K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →